(Q43923311)

28 November 2017

title

Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients (English)

1 reference

28 November 2017

0 references

1 reference

1 reference

1 reference

Hermann LS

1

1 reference

28 November 2017

Kalén J

2

1 reference

28 November 2017

Katzman P

3

1 reference

28 November 2017

Lager I

4

1 reference

28 November 2017

Nilsson A

5

1 reference

28 November 2017

Norrhamn O

6

1 reference

28 November 2017

Sartor G

7

1 reference

28 November 2017

Ugander L

8

1 reference

28 November 2017

publication date

1 December 2001

1 reference

Diabetes, Obesity and Metabolism

28 November 2017

published in

1 reference

28 November 2017

volume

3

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

428-434

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

The use of insulin alone and in combination with oral agents in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

Combination therapy with insulin and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

A risk-benefit assessment of metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2001.00160.X

10.1046/J.1463-1326.2001.00160.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference